Evidence map›Paper›PMID 37163504›Full record

ArticlePloS one2023

Guidance for good practice in the application of machine learning in development of toxicological quantitative structure-activity relationships (QSARs).

Samuel J Belfield, Mark T D Cronin, Steven J Enoch, James W Firman

Abstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Samuel J BelfieldSchool of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, United Kingdom.ORCID 0000-0002-6532-2532
Mark T D CroninSchool of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, United Kingdom.
Steven J EnochSchool of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, United Kingdom.
James W FirmanSchool of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, United Kingdom.ORCID 0000-0003-0319-1407

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent years have seen a substantial growth in the adoption of machine learning approaches for the purposes of quantitative structure-activity relationship (QSAR) development. Such a trend has coincided with desire to see a shifting in the focus of methodology employed within chemical safety assessment: away from traditional reliance upon animal-intensive in vivo protocols, and towards increased application of in silico (or computational) predictive toxicology. With QSAR central amongst techniques applied in this area, the emergence of algorithms trained through machine learning with the objective of toxicity estimation has, quite naturally, arisen. On account of the pattern-recognition capabilities of the underlying methods, the statistical power of the ensuing models is potentially considerable-appropriate for the handling even of vast, heterogeneous datasets. However, such potency comes at a price: this manifesting as the general practical deficits observed with respect to the reproducibility, interpretability and generalisability of the resulting tools. Unsurprisingly, these elements have served to hinder broader uptake (most notably within a regulatory setting). Areas of uncertainty liable to accompany (and hence detract from applicability of) toxicological QSAR have previously been highlighted, accompanied by the forwarding of suggestions for "best practice" aimed at mitigation of their influence. However, the scope of such exercises has remained limited to "classical" QSAR-that conducted through use of linear regression and related techniques, with the adoption of comparatively few features or descriptors. Accordingly, the intention of this study has been to extend the remit of best practice guidance, so as to address concerns specific to employment of machine learning within the field. In doing so, the impact of strategies aimed at enhancing the transparency (feature importance, feature reduction), generalisability (cross-validation) and predictive power (hyperparameter optimisation) of algorithms, trained upon real toxicity data through six common learning approaches, is evaluated.

Indexed as

AlgorithmsQuantitative Structure-Activity RelationshipAnimalsMachine LearningReproducibility of ResultsUncertainty

Identifiers

PMID37163504
PMCPMC10171609

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.